Vaginally Administered PEGylated LIF Antagonist Blocked Embryo Implantation in Mice
Author Information
Author(s): Menkhorst Ellen, Zhang Jian-Guo, Sims Natalie A., Morgan Phillip O., Soo Priscilla, Poulton Ingrid J., Metcalf Donald, Alexandrou Estella, Gresle Melissa, Salamonsen Lois A., Butzkueven Helmut, Nicola Nicos A., Dimitriadis Evdokia
Primary Institution: Prince Henry's Institute, Clayton, Australia
Hypothesis
Can a PEGylated LIF inhibitor (PEGLA) effectively prevent embryo implantation when administered vaginally in mice?
Conclusion
Vaginally administered PEGLA effectively blocked embryo implantation in mice without affecting bone remodeling.
Supporting Evidence
- Vaginally-applied PEGLA blocked implantation in mice.
- Vaginal application reduced the total dose of PEGLA required to block implantation.
- PEGLA had no effect on bone remodeling when administered vaginally.
Takeaway
This study shows that a special drug can be put in the vagina to stop pregnancy without causing problems for bones.
Methodology
Mice were treated with vaginal applications of PEGLA and the number of implantation sites was counted.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
C57BL6/J mice, both mated and non-mated.
Statistical Information
P-Value
p=0.1367
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website